JINJIA(SZ:002191)2022-12-06 01:44Group 1: Company Development and Strategy - The company received formal acceptance from the CSRC for its non-public stock issuance in August and is actively promoting this matter, awaiting further review from the CSRC [1][2] - The company has defined its strategic direction in the health industry, emphasizing the need for further efforts and exploration, including collaborations with various institutions [2][3] - The company plans to increase investments in the health sector following careful consideration of its strategic direction [2][3] Group 2: Financial Performance and Projections - The company anticipates a net profit fluctuation for the year between -15% and 15%, influenced by inventory adjustments and structural changes in the tobacco industry [3][4] - The company aims to achieve better performance despite the challenges faced in the current fiscal year [3][4] Group 3: Packaging Development and Expansion Plans - New facilities in Shenzhen have been put into operation, enhancing production capacity, with notable clients including VIVO and Mizu [3][4] - The company continues to pursue a growth strategy that combines internal growth with external acquisitions, focusing on expanding its market share in the tobacco label sector and investing in packaging companies with core technologies [3][4]